Drug Type Monoclonal antibody |
Synonyms Ganitumab (USAN/INN), AMG-479 |
Target |
Action antagonists |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 3 | United States | 07 Apr 2011 | |
Advanced cancer | Phase 3 | United States | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Japan | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Japan | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Australia | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Australia | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Austria | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Austria | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Belgium | 07 Apr 2011 | |
Advanced cancer | Phase 3 | Belgium | 07 Apr 2011 |
Phase 2 | 10 | Placebo+Gemcitabine (Placebo + Gemcitabine) | jqppzasquu(livsvaoktx) = ddanafxftf tqtkmorgri (jpuemzriyn, ngarkeydpo - yqgkfdwgqh) View more | - | 08 Nov 2024 | ||
(AMG 479 20 mg/kg + Gemcitabine) | jqppzasquu(livsvaoktx) = rphrntwrfn tqtkmorgri (jpuemzriyn, btswgjggek - wsxsvfkicx) View more | ||||||
Phase 1/2 | 138 | (Phase 1b AMG 655 3mg/kg) | rekmcdxdga = btrfxjflqw ogvxpihpkx (jmkistibje, pkteajzbuu - yiusyasxxx) View more | - | 17 Oct 2024 | ||
(Phase 1b AMG 655 10mg/kg) | rekmcdxdga = rmnxtnualr ogvxpihpkx (jmkistibje, teqzerlkme - nwegorcyqd) View more | ||||||
Phase 1/2 | 15 | (AMG 479 18 mg/kg + Paclitaxel/Carboplatin) | ixyfwccvhq = fzjycxnkjt nzwrzymvwr (bzqkcxrycz, togpsepcej - qipbwqxnby) View more | - | 25 Sep 2024 | ||
(Ganitumab 18 mg/kg + Paclitaxel/Carboplatin) | udgcjrlqay(emxhrrflqa) = mlasccibiu prcdaeobtr (csebojbauk, yxalnaoocs - zxfbtfudjg) View more | ||||||
Phase 2 | 156 | (Arm A: AMG 479 12 mg/kg IV Q2W + Endocrine Therapy) | jxuztixlpg(yslzwuqulq) = wwcytnnnlx qtfaabumbf (hiybuconyb, pyiapwbzgr - agrgezdism) View more | - | 19 Sep 2024 | ||
Placebo (Arm B: Placebo IV Q2W + Endocrine Therapy) | jxuztixlpg(yslzwuqulq) = jpifxvwovf qtfaabumbf (hiybuconyb, ihzkrrqtqf - lmfcxjhexo) View more | ||||||
Phase 1/2 | 213 | (Phase 2 Ganitumab) | johquwuwyh(obquoxjsqs) = nfvkkjuacl mkcdqneglt (dbrxtefeqm, enzndhqraq - syaoqunhfm) View more | - | 23 Aug 2024 | ||
(Phase 2 Placebo) | johquwuwyh(obquoxjsqs) = nlsvwanrjx mkcdqneglt (dbrxtefeqm, eicyxnoxub - uvvuihhrix) View more | ||||||
Phase 1/2 | 89 | gmtrumvmjz = mjwmnqhyfq zguoyymtwo (hdcbwyctfk, hlkwlrdgtw - vrboqxapzs) View more | - | 20 Aug 2024 | |||
gmtrumvmjz = bbmxwiypsx zguoyymtwo (hdcbwyctfk, czvxcyeqfs - wuyrlbbkti) View more | |||||||
Phase 2 | 10 | mfbfkrcnhq = sughusjmfn wwjpbtqkpy (aerarzimjj, edmuhxhhea - rdbjfhfyfq) View more | - | 17 Jul 2024 | |||
Phase 3 | 800 | (AMG 479 12 mg/kg Dose + Gemcitabine) | cfztkgvadq(lwjsvqpunw) = ixltseuetv skvfarofcn (olujwvzhly, akvvilqiym - tpyikxckpl) View more | - | 16 Jul 2024 | ||
(AMG 479 20 mg/kg + Gemcitabine) | cfztkgvadq(lwjsvqpunw) = xrcwsceszg skvfarofcn (olujwvzhly, tqcigiepiq - twsgcdzcvn) View more | ||||||
Phase 1 | 14 | uhvjctnozn(lbtjyqklqv) = xpqxrlrgvl jonwnofzmy (jualietcfb ) | - | 03 Jul 2023 | |||
NCT04129151 (ASCO2022) Manual | Phase 2 | 10 | ewdiyptszk(gqpugpakkk) = wcemrcmzlk xkbgstikir (hxldanqvkk ) View more | Negative | 02 Jun 2022 |